pp电子网址
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2017.09.30
2017年第四次临时股东大会决议公告
2017.09.26
关于公司复牌的公告
2017.09.26
关于发行股份购买资产暨关联交易报告书修订说明的公告
2017.09.26
关于深圳交易所重组问询函之回复
2017.09.26
中天国富有限公司关于深圳交易所《关于对深圳市pp电子网址药业集团股份有限公司的重...
2017.09.26
北京市中伦律师事务所关于公司发行股份购买资产暨关联交易的补充法律意见书
2017.09.26
发行股份购买资产暨关联交易报告书(草案)
2017.09.26
发行股份购买资产暨关联交易报告书(草案)摘要
2017.09.20
关于筹划发行股份购买资产的停牌进展公告
2017.09.13
关于筹划发行股份购买资产的停牌进展公告
第一页
上一页
68
69
70
71
72
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.